Before Invest
AMGEN INC logo

AMGEN INC

AMGN
Biological Products No Disgnostic Substances
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 40 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Current assets:
                                                    
Cash and cash equivalents
$ 13,989
$ 12,038
$ 9,445
$ 8,028
$ 8,810
$ 9,011
$ 9,301
$ 9,708
$ 34,741
$ 34,248
$ 31,560
$ 9,502
Marketable securities
-
-
-
-
-
-
-
-
0
0
1
1,976
Receivable from sale of investments
-
-
-
-
-
-
-
-
-
-
-
-
Trade receivables, net
10,227
9,138
8,490
8,701
8,132
7,317
6,934
6,776
6,145
5,830
5,736
5,326
Inventories
6,220
6,186
6,346
6,583
6,729
7,362
7,995
8,724
5,026
4,978
5,011
4,757
Other current assets
4,525
4,113
3,604
3,422
3,258
3,076
2,976
2,821
2,565
2,324
2,395
2,501
Total current assets
34,961
31,475
27,885
26,734
26,929
26,766
27,206
28,029
48,477
47,380
44,703
24,062
Property, plant and equipment, net
8,547
8,216
7,220
6,855
6,681
6,156
6,097
6,002
5,563
5,532
5,460
5,188
Intangible assets, net
20,487
21,379
23,139
24,614
25,724
28,920
30,172
31,372
13,150
14,633
15,393
13,266
Goodwill
18,668
18,674
18,676
18,674
18,645
18,658
18,616
18,570
15,509
15,531
15,531
14,845
Restricted investments
-
-
-
-
-
-
-
-
-
-
-
-
Other noncurrent assets
12,976
12,760
13,221
11,020
11,388
10,383
8,816
9,007
7,835
7,193
7,633
6,339
Total assets
95,639
92,504
90,141
87,897
89,367
90,883
90,907
92,980
90,534
90,269
88,720
63,700
LIABILITIES AND STOCKHOLDERS’ EQUITY
                                                    
Current liabilities:
                                                    
Accounts payable
2,865
2,935
2,838
3,010
2,406
2,147
2,267
1,628
1,358
1,212
1,320
1,204
Accrued liabilities
17,192
16,583
16,800
15,022
17,234
14,621
13,722
14,127
14,168
13,718
12,061
11,584
Current portion of long-term debt
5,445
5,437
2,153
2,444
3,368
3,544
5,528
3,959
1,428
2,167
834
1,543
Short-term borrowings and current portion of long-term debt
-
-
-
-
-
-
-
-
-
-
-
-
Commercial paper borrowings
-
-
-
-
-
-
-
-
-
-
-
-
Current portion of convertible notes
-
-
-
-
-
-
-
-
-
-
-
-
Total current liabilities
25,502
24,955
21,791
20,476
23,008
20,312
21,517
19,714
16,954
17,097
14,215
14,331
Long-term debt
51,859
51,886
52,434
53,760
54,013
56,854
57,117
60,061
59,040
59,377
60,761
37,161
Long-term deferred tax liabilities
1,301
1,344
1,458
1,386
1,510
1,711
1,780
1,862
-
-
-
-
Long-term tax liabilities
2,844
2,764
2,616
2,511
2,419
2,280
2,205
3,964
4,579
4,478
5,864
5,680
Convertible notes
-
-
-
-
-
-
-
-
-
-
-
-
Other noncurrent liabilities
2,445
2,365
2,223
2,336
2,210
2,199
2,363
2,357
2,305
2,536
2,532
2,875
Commitments and contingencies
-
-
-
-
-
-
-
-
-
-
-
-
Stockholders’ equity:
                                                    
Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding—540.6 shares in 2026 and 538.8 shares in 2025
34,082
34,030
33,841
33,680
33,578
33,393
33,204
33,082
32,753
32,601
32,535
32,371
Accumulated deficit
(22,275)
(24,650)
(23,800)
(25,708)
(27,140)
(25,530)
(27,124)
(27,870)
(24,971)
(25,540)
(26,919)
(28,066)
Accumulated other comprehensive loss
(119)
(190)
(422)
(544)
(231)
(336)
(155)
(190)
(126)
(280)
(268)
(652)
Total stockholders’ equity
11,688
9,190
9,619
7,428
6,207
7,527
5,925
5,022
7,656
6,781
5,348
3,653
Total liabilities and stockholders’ equity
$ 95,639
$ 92,504
$ 90,141
$ 87,897
$ 89,367
$ 90,883
$ 90,907
$ 92,980
$ 90,534
$ 90,269
$ 88,720
$ 63,700